We all age. And while humanity's life expectancy has increased dramatically in the modern era, we still struggle with the ...

Protein design aims to create customized antibodies for therapies, biosensors for diagnostics, or enzymes for chemical ...

Scientists have identified human antibodies capable of targeting the proteins responsible for severe malaria, potentially paving the way for new vaccines or treatments. Using organ-on-a-chip ...

As part of an international collaboration, Fred Hutch scientists provided structural information that helped reveal how two ...

Alector’s AbbVie-partnered Alzheimer's asset has failed to slow disease progression in a phase 2 study, the latest in a ...

Nature is adept at designing proteins. Scientists are even better. But artificial intelligence holds the promise of improving ...

CPP clusters offer a breakthrough in delivering therapeutics across biological barriers, with potential applications in ...

NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced ...

Maternal RSV vaccination enhances antibody transfer to newborns, with optimal transfer efficiency observed when given at ...

AI is finding its way into every corner of biotech and pharmaceutical research, but like other industries, it's never quite as straightforward to ...

Last year, Coskun and his team introduced a new study in “single cell spatial metabolomics,” which explores the distribution ...